23 matches.
- The DEA Is Knocking at Your Door . . . Are You Prepared?
- The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
- FDA Releases Laboratory-Developed Tests Final Rule
- Telehealth Post-Public Health Emergency: What to Expect in 2024
- What to Do If the Government Knocks on Your Company’s Door … or Breaks It Down
- Dietary Supplements: Navigating the Regulatory Maze
- Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
- The Legal Battle Over Mifepristone
- Direct Access Laboratory Testing: Physician Orders and Specimen Collection
- The End of the Public Health Emergency – What’s to Come?
- Direct Access Laboratory Testing: Reimbursement & Compliance
- Direct Access Laboratory Testing: Navigating the Regulatory Landscape
- Post-Dobbs: Considerations for Clinical Trials and Research
- Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
- Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape
- Health Care's Past, Present, and Future
- Hot Areas in COVID-19 Enforcement, Testing, and Funding
- DOJ Goes After Civil Cyber-Fraud
- On the Ballot 2020: Health Care Policy Outlook
- Fraud and Abuse Enforcement Priorities in the Wake of COVID-19
- Trends in Antitrust: Thought Leaders in Health Law Video Series
- Trends in Fraud and Abuse in Home Care: Thought Leaders in Health Law Video Series
- Trends in Individual Accountability in Health Care Fraud Enforcement: Thought Leaders in Health Law Video Series